SAMDaily.us | AWARD | A | Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

SAMDAILY.US - ISSUE OF OCTOBER 16, 2025 SAM #8725
AWARD

A -- Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

Notice Date: 10/14/2025 4:15:33 AM
Notice Type: Award Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
ZIP Code: 20515
Solicitation Number: 75A50125C00017
Archive Date: 10/15/2025
Point of Contact: BARDA-BAA@hhs.gov, Ryan Marion
E-Mail Address: BARDA-BAA@hhs.gov, ryan.marion@hhs.gov
(BARDA-BAA@hhs.gov, ryan.marion@hhs.gov)
Small Business Set-Aside: NONE No Set aside used
Award Number: 75A50125C00017
Award Date: 09/30/2025
Awardee: CIDARA THERAPEUTICS INC San Diego CA 92121 USA
Award Amount: 339189481.00
Web Link: SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/0e9dadb61bd9407988920c7bec1d1324/view)
Place of Performance: Address: San Diego, CA 92121, USA; Zip Code: 92121; Country: USA
Record: SN07617405-F 20251016/251014230031 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |